FIVN Form 144 Notice: Insider Plans Sale of 10,860 RSU Shares
Rhea-AI Filing Summary
Five9, Inc. (FIVN) filing a Form 144 notifies the proposed sale of 10,860 shares of common stock to be effected through Morgan Stanley Smith Barney LLC on 09/04/2025, with an aggregate market value listed at $287,572.80. The shares were acquired the prior day, 09/03/2025, as Restricted Stock Units granted by the issuer and payment/consideration is listed as N/A for the acquisition.
The filing also discloses related recent sales: a Rule 10b5-1 sale on 08/13/2025 of 7,043 shares for gross proceeds of $181,746.73. The notice includes the standard representation that the seller does not possess undisclosed material adverse information and references reliance on any 10b5-1 plan where applicable.
Positive
- Disclosure of acquisition type as Restricted Stock Units provides clarity on the source of shares.
- Planned sale date and broker (Morgan Stanley Smith Barney LLC) are specified, improving transparency.
- Prior 10b5-1 sale on 08/13/2025 is disclosed, showing recent insider transaction history.
Negative
- None.
Insights
TL;DR: Routine insider sale of recently vested RSUs disclosed under Rule 144; prior 10b5-1 sale also reported.
The filing shows a proposed immediate disposition of 10,860 common shares through Morgan Stanley, acquired as restricted stock units on 09/03/2025. Disclosure of both the acquisition type and the planned sale date provides transparency on timing and source of the shares. The prior 10b5-1 sale on 08/13/2025 (7,043 shares) is included, indicating recent insider liquidity activity. From a trading-impact perspective this appears to be routine insider monetization rather than a corporate-action or financing event.
TL;DR: Documentation aligns with Rule 144 requirements and includes 10b5-1 disclosure; no governance red flags in the notice itself.
The form identifies the securities as RSU-derived common shares and lists the broker and approximate sale details, satisfying standard Form 144 disclosure elements. The signer asserts no undisclosed material adverse information and references plan adoption/instruction dates when relying on 10b5-1 protections. The filing is procedural and does not, by itself, indicate governance concerns; it documents insider compliance with required notice obligations.